BSECompany Update1d ago · 21 Jul 2026, 01:49 pm
Pls find enclosed Revised Investor Call Intimation
Ajanta Pharma Ltd · 532331
✦ AI SummaryResults
Ajanta Pharma Ltd has announced a revised timing for its earnings conference call scheduled to be held on July 30, 2026, after the board meeting. The call will now take place at 4:15 p.m. IST, and the company will release its Q1 FY 2027 unaudited financial results on the same day at 4:15 p.m. IST.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Ajanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Attachments (1)
📄pdf
Download →
d5639c55-6b31-4c84-bbfe-4062986ee629.pdf
View document text
Ajanta Pharma Limited
Ajanta Tower, 54-A, M V Road, T +91 22 6060 9000
Chakala, Andheri (E), E legal.info@ajantapharma.com
Mumbai – 400 093, India W www.ajantapharma.com
21st July 2026
BSE Limited National Stock Exchange of India,
Phiroze Jeejeebhoy Towers Exchange Plaza, 5th Floor, Plot No. C/1,
Dalal Street, G block, Bandra Kurla Complex,
Mumbai - 400 001 Bandra (East), Mumbai - 400 051
Scrip Code: BSE – AJANTPHARM 532331 Scrip Code: NSE AJANTPHARM EQ
Sub: Earnings Conference Call
Dear Sir / Madam,
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015, we wish to inform you that the timing of the Earnings Conference Call scheduled to be held on
Thursday, 30th July, 2026, post the Board Meeting, has been revised from 4:30 p.m. (IST) to 4:15 p.m.
(IST). Please find enclosed the revised Earnings Conference Call intimation.
This is for your information and records please.
Yours Faithfully,
Gaurang Shah
Sr. VP – Legal & Company Secretary
Encl.: a/a
Page 1 of 2
Corporate Identity Number - L24230MH1979PLC022059
Ajanta Pharma Limited
Ajanta Tower, 54-A, M V Road, T +91 22 6060 9000
Chakala, Andheri (E), E legal.info@ajantapharma.com
Mumbai – 400 093, India W www.ajantapharma.com
Announcement
Ajanta Pharma to release Q1 FY 2027 Unaudited Financial Results on 30th July, 2026
16:15 hrs. – EARNINGS CONFERENCE CALL
The Company will host an Earnings Conference Call at 16:15 hrs. IST (18:45 hrs. SST/HKT, 11:45 hrs.
BST, 06:45 hrs. US ET), during which the leadership team will discuss the financial performance and
take questions. A transcript of the conference call will be available at www.ajantapharma.com.
Earnings Conference Call Dial-in Information
Date and Time July 30, 2026 at
16:15 – 17:15 hrs IST
18:45 – 19:45 hrs SST/HKT
11:45 – 12:45 hrs BST
06:45 – 07:45 hrs US ET
Dial-in Numbers
Diamond pass link for faster access Click here to register
Universal Access Primary Access: (+91 22 6280 1542)
(+91 22 7115 8372)
International Toll Free USA: 18667462133
UK: 08081011573
Hong Kong: 800964448
Singapore: 8001012045
For convenience and faster connectivity to the conference, kindly follow the below steps:
1. Register through the Diamond pass link.
2. You will receive a calendar invite along with a passcode and a PIN number. The passcode and
PIN will be activated 30 minutes prior to the conference scheduled time.
3. Dial the ‘conference Dial-in number’ you will receive on your email.
4. On system prompt dial the PASSCODE followed by # key.
5. On system prompt enter the PIN followed by # key.
6. If the line gets disconnected, you need to dial the ‘conference dial-in number’ again and follow
the necessary steps.
Playback of Earnings Conference Call audio:
Playback of the earnings call will be available 120 minutes after the end of the call on our website
(www.ajantapharma.com).
Contact:
Investor Relations
Rajeev Agarwal Abhineet Kumar
E-Mail: rajeev.agarwal@ajantapharma.com E-Mail: abhineet.kumar@ajantapharma.com
Page 2 of 2
Corporate Identity Number - L24230MH1979PLC022059